North America Kidney Cancer Therapeutics & Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The North America Kidney Cancer Therapeutics & Diagnostics Market is segmented by Cancer Type, Component (Drugs and Diagnostics) and Geography.

North America Kidney Cancer Therapeutics & Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

North America Kidney Cancer Therapeutics & Diagnostics Market Size

View Global Report
Market Snapshot1
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 5.80 %

Major Players

North America Kidney Cancer Therapeutics & Diagnostics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of North America Kidney Cancer Therapeutics & Diagnostics Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

North America Kidney Cancer Therapeutics & Diagnostics Market Analysis

The North America Kidney Cancer Therapeutics & Diagnostics Market is expected to register a CAGR of 5.8% during the forecast period.

According to GLOBOCAN 2018, in 2018, there were about 60,336 new kidney cancer cases and the mortality was approximately 15,333 cases in the United States.

Furthermore, changes in lifestyle, excessive smoking, increased consumption of alcohol, and a rise in obesity because of sedentary life routines lead to the growing incidence of the disease. Thus, owing to the above factors the North America kidney cancer therapeutics & diagnostics market is expected to significant growth over the forecast period.

North America Kidney Cancer Therapeutics & Diagnostics Industry Overview

The North America Kidney Cancer Therapeutics & Diagnostics Market is moderately consolidated competitive. Product innovation and ongoing R&D activities to develop advanced technologies has helped in boosting the growth of the market. Some of the companies which are currently dominating the market are Bayer AG, F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc, Abbott Laboratories, Amgen Inc, and Seattle Genetics.

North America Kidney Cancer Therapeutics & Diagnostics Market Leaders

  1. Pfizer Inc

  2. F. Hoffmann-La Roche Ltd

  3. Bayer AG

  4. Novartis AG

  5. Amgen Inc

  6. *Disclaimer: Major Players sorted in no particular order
NA landscape.png
Need More Details on Market Players and Competiters?
Download PDF

North America Kidney Cancer Therapeutics & Diagnostics Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Number of Kidney Cancer Cases
    • 4.2.2 Increased R&D Expenditure of Pharmaceutical Companies
  • 4.3 Market Restraints
    • 4.3.1 High Cost Associated with Treatment
    • 4.3.2 Preference for Generic Drugs
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Cancer Type
    • 5.1.1 Clear cell RCC
    • 5.1.2 Papillary RCC
    • 5.1.3 Chromophobe RCC
    • 5.1.4 Urothelial carcinoma/Transitional cell carcinoma
    • 5.1.5 Other Kidney cancers (Wilms tumor, Renal sarcoma, Collecting duct RCC)
  • 5.2 By Component
    • 5.2.1 Drugs
    • 5.2.1.1 Therapeutic Class
    • 5.2.1.1.1 Targeted Therapy
    • 5.2.1.1.2 Immunotherapy
    • 5.2.1.1.3 Other Therapeutic Class
    • 5.2.1.2 Pharmacologic Class
    • 5.2.1.2.1 Angiogenesis Inhibitors
    • 5.2.1.2.2 Monoclonal Antibodies
    • 5.2.1.2.3 mTOR Inhibitors
    • 5.2.1.2.4 Cytokine Immunotherapy (IL-2)
    • 5.2.2 Diagnostics
    • 5.2.2.1 Biopsy
    • 5.2.2.2 Imaging Tests
    • 5.2.2.3 Blood Tests
    • 5.2.2.4 Other Diagnostics
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Pfizer Inc
    • 6.1.2 F. Hoffmann-La Roche Ltd
    • 6.1.3 Bayer AG
    • 6.1.4 Novartis AG
    • 6.1.5 Amgen Inc
    • 6.1.6 Abbott Laboratories
    • 6.1.7 Cerulean Pharma Inc
    • 6.1.8 Eisai co Ltd
    • 6.1.9 Seattle Genetic
    • 6.1.10 GlaxoSmithKline PL
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

North America Kidney Cancer Therapeutics & Diagnostics Industry Segmentation

As per the scope of the report, kidney cancer is a type of cancer that starts in kidney cells. The kidney cancer therapeutics and diagnostics involve therapy and diagnostics methods that are used for the treatment of renal cancer. The North America kidney cancer therapeutics & diagnostics market is segmented by cancer type, component and geography.

By Cancer Type Clear cell RCC
Papillary RCC
Chromophobe RCC
Urothelial carcinoma/Transitional cell carcinoma
Other Kidney cancers (Wilms tumor, Renal sarcoma, Collecting duct RCC)
By Component Drugs Therapeutic Class Targeted Therapy
Immunotherapy
Other Therapeutic Class
Pharmacologic Class Angiogenesis Inhibitors
Monoclonal Antibodies
mTOR Inhibitors
Cytokine Immunotherapy (IL-2)
Diagnostics Biopsy
Imaging Tests
Blood Tests
Other Diagnostics
Geography North America United States
Canada
Mexico
Need A Different Region or Segment?
Customize Now

North America Kidney Cancer Therapeutics & Diagnostics Market Research FAQs

What is the current North America Kidney Cancer Therapeutics & Diagnostics Market size?

The North America Kidney Cancer Therapeutics & Diagnostics Market is projected to register a CAGR of 5.8% during the forecast period (2025-2030)

Who are the key players in North America Kidney Cancer Therapeutics & Diagnostics Market?

Pfizer Inc, F. Hoffmann-La Roche Ltd, Bayer AG, Novartis AG and Amgen Inc are the major companies operating in the North America Kidney Cancer Therapeutics & Diagnostics Market.

What years does this North America Kidney Cancer Therapeutics & Diagnostics Market cover?

The report covers the North America Kidney Cancer Therapeutics & Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the North America Kidney Cancer Therapeutics & Diagnostics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

North America Kidney Cancer Therapeutics & Diagnostics Industry Report

Statistics for the 2025 North America Kidney Cancer Therapeutics & Diagnostics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Kidney Cancer Therapeutics & Diagnostics analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

North America Kidney Cancer Therapeutics & Diagnostics Market Report Snapshots